BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37015317)

  • 1. Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps.
    Watanabe H; Kubo M; Taniguchi A; Asano Y; Hiramatsu-Asano S; Ohashi K; Zeggar S; Katsuyama E; Katsuyama T; Sunahori-Watanabe K; Sada KE; Matsumoto Y; Yamamoto Y; Yamamoto H; Son M; Wada J
    Clin Immunol; 2023 May; 250():109317. PubMed ID: 37015317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.
    Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ
    Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of
    Hiramatsu-Asano S; Sunahori-Watanabe K; Zeggar S; Katsuyama E; Mukai T; Morita Y; Wada J
    Front Immunol; 2020; 11():616141. PubMed ID: 33574820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dampened Inflammation and Improved Survival After CXCL5 Administration in Murine Lupus via Myeloid and Neutrophil Pathways.
    Fan X; Ng CT; Guo D; Lim F; Tan JC; Law A; Goh LH; Poon ZY; Cheung A; Kong SL; Tan M; Li S; Loh A; James A; Lim T; Chen J; Thumboo J; Hwang W; Low A
    Arthritis Rheumatol; 2023 Apr; 75(4):553-566. PubMed ID: 36240108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
    J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
    Chen XC; Wu D; Wu HL; Li HY; Yang C; Su HY; Liu ZJ; Huang XR; Lu X; Huang LF; Zhu SP; Pan QJ; An N; Liu HF
    Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4
    Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA
    BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin.
    James WG; Hutchinson P; Bullard DC; Hickey MJ
    Clin Exp Immunol; 2006 May; 144(2):299-308. PubMed ID: 16634804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition.
    Pieterse E; Rother N; Garsen M; Hofstra JM; Satchell SC; Hoffmann M; Loeven MA; Knaapen HK; van der Heijden OWH; Berden JHM; Hilbrands LB; van der Vlag J
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1371-1379. PubMed ID: 28495931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mdm2 promotes systemic lupus erythematosus and lupus nephritis.
    Allam R; Sayyed SG; Kulkarni OP; Lichtnekert J; Anders HJ
    J Am Soc Nephrol; 2011 Nov; 22(11):2016-27. PubMed ID: 21949095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C; Zhao ML; Scearce RM; Diaz M
    Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.